m
m (Added embedded dosage calculation)
Line 8: Line 8:
| routes = Intravenous
| routes = Intravenous
| dosage =  
| dosage =  
| dosage_calculation = esmolol
| mechanism = Beta-1 antagonism
| mechanism = Beta-1 antagonism
| adverse_effects =  
| adverse_effects =  

Revision as of 00:57, 30 March 2022

Esmolol
Trade names

Brevibloc

Esmolol.svg
Clinical data
Drug class

Beta blocker

Routes of administration

Intravenous

Dosage
Load
  • 0.5-1 mg/kg IV
Maintenance
  • 50-300 mcg/kg/min IV
Indication 
Route 
Intravenous

Titrate infusion by 50 mcg/kg/min q4m until desired effect achieved.

  1. Pevtsov A, Kerndt CC, Fredlund KL. Esmolol. [Updated 2021 Aug 2]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK518965/
Pharmacodynamics
Mechanism of action

Beta-1 antagonism

Pharmacokinetics
Physical and chemical data
Article quality
Editor rating
Unrated
User likes
0

Provide a brief summary of this drug here.

Uses

Contraindications

Absolute contraindications

Precautions

Pharmacology

Pharmacodynamics

Mechanism of action

Adverse effects

Pharmacokinetics

Chemistry and formulation

History

References